Lucknow – With India recording over 1.4 million new cancer cases each year, access to advanced treatment methods remains a pressing challenge, especially outside major cities. Elekta, a global leader in precision radiation therapy, is taking the lead in bridging this gap by training oncologists in Adaptive Radiation Therapy (ART), a cutting-edge technique that customizes treatment in real time to a patient’s anatomy.
ART uses daily high-quality imaging to adapt treatment plans, ensuring tumors are targeted more accurately even when changes occur in size, shape, or position. This reduces radiation exposure to healthy organs, lowering side effects while improving patient outcomes.
To scale this innovation, Elekta hosted Elekta Connect in Lucknow – a hands-on workshop and symposium featuring live ART demonstrations, expert lectures, and panel discussions.
“Adaptive radiation therapy is no longer aspirational – it is fast becoming a standard of care in India,” said Shankar Seshadri, Vice President, Elekta India.
Leading oncologists, including Dr. Sharad Singh (Kalyan Super Specialty Cancer Institute, Lucknow), Dr. Neeraj Rastogi (Medanta Hospital, Lucknow), Dr. Shaleen Kumar (Dean, SGPGI Lucknow), and Dr. M. Suneetha (Yashoda Hospitals, Hyderabad), highlighted ART’s transformative role in reducing toxicities, improving tumor control, and enhancing quality of life for patients.
By bringing ART to the forefront of India’s oncology ecosystem, Elekta aims to ensure that precision cancer care reaches patients across regions, offering hope of safer, more effective treatments nationwide.
